Communiqués Lavipharm S.A.

Actions

LAVI

GRS246003008

Produits pharmaceutiques

Temps Différé Athens S.E. 11:17:45 13/08/2026			Varia. 5j.	Varia. 1 janv.
1,560 ^EUR	-0,64%		-0,76%	+60,82%

25/06	Lavipharm S.A. annonce le versement d'un dividende annuel, payable le 24 juillet 2026	CI
28/05	Lavipharm : le résultat avant impôt des activités poursuivies grimpe de 28,6% au T1, à 1,41 million d'euros	RE

Communiqués

11/06	Lavipharm S A : Announcement Appointment of Chief Quality Officer	PU
22/05	Lavipharm S A : IMPORTANT CORPORATE EVENTS	PU
07/11	Lavipharm S A : OTHER ANNOUNCEMENTS	PU
15/10/25	Lavipharm S A : ANNOUNCEMENT OF REGULATED INFORMATION - TRANSACTIONS NOTIFICATION	PU
13/10/25	Lavipharm S A : ANNOUNCEMENT OF REGULATED INFORMATION - TRANSACTIONS NOTIFICATION	PU
18/09/25	Lavipharm S A : FINANCIAL RESULTS PRESS RELEASE FIRST HALF 2025	PU
15/07/25	Lavipharm S A : CORPORATE ACTIONS	PU
11/06/25	Lavipharm S A : Announcement 4310/2025	PU
08/05/25	Lavipharm S A : Announcement of New Head of Corporate Announcements	PU
14/04/25	Lavipharm S A : Announcement 2561/2025	PU
23/01/25	Lavipharm S A : A New Strategic Agreement for Further Expansion in International Markets	PU
14/11/24	Lavipharm S A : 9-month 2024 Key Financial Figures	PU
19/09/24	Lavipharm S A : FINANCIAL RESULTS FIRST HALF OF 2024	PU
09/07/24	Lavipharm S A : PRESS RELEASE	PU
09/07/24	Lavipharm S A : Announcement 5720/2024	PU
17/06/24	Lavipharm S A : Announcement 4879/2024	PU
24/04/24	Lavipharm S A : Annual Analysts Briefing	PU
11/12/23	Lavipharm S A : ANNOUNCEMENT	PU
11/12/23	Lavipharm S A : enters into a new asset purchase agreement	PU
01/12/23	Lavipharm S A : Asset Purchase Agreement for Lavipharm	PU
21/09/23	Lavipharm S A : FINANCIAL RESULTS FIRST HALF OF 2023	PU
21/09/23	Lavipharm S A : First Half 2023 Financial Results – Strong EBITDA increase	PU
06/07/23	Lavipharm S A : Annual Shareholders’ Meeting	PU
06/07/23	Lavipharm S A : PRESS RELEASE SHAREHOLDERS MEETING	PU
26/05/23	Lavipharm S A : Press Release Extraordinary Shareholders’ Meeting	PU